Clearside Biomedical, Inc.

NASDAQ:CLSD

1.23 (USD) • At close September 13, 2024
Bedrijfsnaam Clearside Biomedical, Inc.
Symbool CLSD
Munteenheid USD
Prijs 1.23
Beurswaarde 91,937,088
Dividendpercentage 0%
52-weken bereik 0.65 - 2.12
Industrie Biotechnology
Sector Healthcare
CEO Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Website https://www.clearsidebio.com

An error occurred while fetching data.

Over Clearside Biomedical, Inc.

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for

Vergelijkbare Aandelen

Eliem Therapeutics, Inc. logo

Eliem Therapeutics, Inc.

ELYM

8.46 USD

Homology Medicines, Inc. logo

Homology Medicines, Inc.

FIXX

0.935 USD

Synlogic, Inc. logo

Synlogic, Inc.

SYBX

1.4 USD

Enlivex Therapeutics Ltd. logo

Enlivex Therapeutics Ltd.

ENLV

1.57 USD

Miromatrix Medical Inc. logo

Miromatrix Medical Inc.

MIRO

3.39 USD

LENSAR, Inc. logo

LENSAR, Inc.

LNSR

5.06 USD

eFFECTOR Therapeutics, Inc. logo

eFFECTOR Therapeutics, Inc.

EFTR

0.04 USD

aTyr Pharma, Inc. logo

aTyr Pharma, Inc.

LIFE

1.9 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)